Matsuoka K, Motoya S, Yamamoto T, Matsuura M, et al. Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data. J Gastroenterol 2025 Apr 21. doi: 10.1007/s00535-025-02249.
PMID: 40259041